• CHI3L1 Inhibition by Z17 Restores Amyloid Clearance in Astro

  2026-06-26

  The reference study identifies Compound Z17 (CHI3L1-IN-5) as a selective inhibitor of chitinase-3-like protein 1 (CHI3L1), demonstrating its ability to block the CHI3L1-mediated NF-κB inflammatory pathway and restore amyloid-beta (Aβ) clearance function in human astrocytes. These findings position Z17 as a promising tool for mechanistic studies and therapeutic development in Alzheimer's disease and neuroinflammation.

• Sulfo-Cy3 Azide for High-Fidelity Mapping of Neurogenetic Gr

  2026-06-26

  Explore how Sulfo-Cy3 azide, a leading bioconjugation reagent, empowers high-resolution fluorescence mapping of neurogenetic gradients. This article offers actionable insights into advanced Click Chemistry labeling for developmental neuroscience, including protocol guidance and a critical analysis of recent reference breakthroughs.

• (R,S)-Anatabine: Precision Amyloid Modulation for Translatio

  2026-06-25

  This article explores how (R,S)-Anatabine, a minor tobacco alkaloid and potent amyloid-beta modulator, empowers translational researchers to bridge mechanistic insight with actionable workflows in Alzheimer's disease and beyond. By connecting recent advances in soluble Aβ peptide reduction with lessons from skin barrier biology, it offers a perspective on designing robust in vitro and in vivo Alzheimer's models and integrating cross-domain learnings for next-generation neurodegeneration research.

• CHI3L1-IN-5 (Compound Z17): Redefining NF-κB Pathway Inhibit

  2026-06-25

  Explore how CHI3L1-IN-5 (Compound Z17) achieves precise, dual-action inhibition of the CHI3L1-mediated NF-κB pathway. This article delves into its unique pharmacological advances, rigorous structure-activity optimization, and implications for translational neurodegeneration research.

• ML385 and NRF2 Inhibition: Redefining Resistance and Redox C

  2026-06-24

  Explore ML385, a leading NRF2 inhibitor, and its role in dissecting cancer therapeutic resistance and oxidative stress regulation. This article offers novel insights into practical assay design, translational applications, and the latest evidence from liver disease research.

• Diuron (3-(3,4-dichlorophenyl)-1,1-dimethylurea) in Toxicolo

  2026-06-23

  Diuron’s precise mechanism as a photosynthesis inhibitor makes it indispensable for plant biology and toxicology studies. Recent breakthroughs reveal its nephrotoxic effects via the JAK2/STAT1 pathway, offering new assay models and risk assessment tools. This guide translates cutting-edge evidence into reproducible workflows and troubleshooting strategies for advanced research.

• PKH26 Red Fluorescent Cell Linker Kit: Technical Guidance

  2026-06-23

  The PKH26 Red Fluorescent Cell Linker Kit enables stable, membrane-specific red fluorescent labeling for cell tracing and proliferation detection in both in vitro and in vivo research. It is best suited for applications requiring robust, long-term cell membrane labeling, and should not be used for intracellular or non-membrane targets.

• Redefining Extrahepatic mRNA Immunotherapy: IL-12 mRNA as a

  2026-06-22

  This thought-leadership article synthesizes mechanistic insights and translational strategies for leveraging EZ Cap™ Mouse IL-12 mRNA (m1Ψ) in next-generation immunotherapy. It examines how advanced mRNA design and virus-mimicking delivery systems unlock extrahepatic targeting, providing actionable guidance for researchers eager to innovate beyond the hepatic paradigm.

• Dacarbazine: Mechanistic Insight and Translational Impact

  2026-06-22

  This thought-leadership article explores how advances in in vitro modeling, systems biology, and strategic protocol design are transforming the translational application of Dacarbazine, a benchmark antineoplastic chemotherapy drug. We synthesize mechanistic insights, competitive positioning, and clinical imperatives, offering actionable guidance for cancer researchers and translational teams.

• Z-VAD-FMK in Apoptosis Research: Protocols and Optimization

  2026-06-21

  Z-VAD-FMK delivers precise, irreversible caspase inhibition for apoptosis pathway dissection in both cell and animal models. This guide translates recent mechanistic advances into actionable workflows for robust, interference-free data.

• Stiripentol: LDH Inhibitor Workflows for Epilepsy & Immunome

  2026-06-20

  Stiripentol, an advanced LDH inhibitor, unlocks precision modulation of lactate metabolism for both epilepsy and tumor microenvironment research. Explore proven workflows, troubleshooting strategies, and how recent discoveries in lactate-driven epigenetic regulation can be leveraged for impactful scientific outcomes.

• DFCP1 Regulates Starvation-Induced ATGL Lipolysis in Lipid D

  2026-06-19

  This study identifies Double FYVE Domain Containing Protein 1 (DFCP1) as a nutrient-sensitive and direct regulator of adipose triglyceride lipase (ATGL)-driven lipid droplet lipolysis during starvation. The findings clarify the mechanism of lipid mobilization under nutrient stress and provide new insights for metabolic disease research and advanced protein complex stability protocols.

• MPC-Driven Lactate, Histone Lactylation, and Tumor Immunity

  2026-06-19

  This study uncovers how downregulation of the mitochondrial pyruvate carrier (MPC) in colorectal cancer elevates lactate production, driving histone lactylation in dendritic cells and impairing antitumor immune responses. By linking metabolic reprogramming to epigenetic regulation and immunotherapy efficacy, the findings highlight new targets for modulating the tumor microenvironment.

• Amyloid Beta-Peptide (1-40) (human): Applied Workflows in Al

  2026-06-18

  Amyloid Beta-Peptide (1-40) (human) is the gold-standard synthetic peptide for modeling amyloid aggregation and neurotoxicity in Alzheimer’s disease research. This guide delivers actionable workflows, highlights advanced imaging applications, and provides troubleshooting insights to accelerate your experimental success.

• Triacetin Digestion and Metabolic Impact: Insights from Rat

  2026-06-18

  This study provides the first detailed investigation into the digestion and absorption of triacetin, a short-chain triacylglycerol, in rats. By elucidating how triacetin is metabolized to acetic acid and glycerol—modulating hepatic gene expression and AMPK activation—the paper highlights new avenues for dietary modulation of metabolic health.

16137 records 1/1076 page Next 12345 下5页 Last page